BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35385884)

  • 21. miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma.
    Yu L; Meng M; Bao Y; Zhang C; Gao B; Sa R; Luo W
    Yonsei Med J; 2019 Sep; 60(9):832-841. PubMed ID: 31433581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells.
    Qiu R; Ma G; Li X; Shi Q; Li X; Zhou X; Tang Y; Xie Z; Liao S; Qin Y; Wang R; Ye Y; Luo J; Zhang J
    J Cell Biochem; 2019 Jun; 120(6):10697-10706. PubMed ID: 30652346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
    Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
    J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
    Han Z; Shi L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
    Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
    Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect and mechanism of quercetin on proliferation and apoptosis of human osteosarcoma cell U-2OS/MTX300].
    Yin J; Xie X; Jia Q; Wang J; Huang G; Zou C; Shen J
    Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):611-4. PubMed ID: 22693904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
    Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth inhibition of Saos-2 osteosarcoma cells by lactucopicrin is mediated via inhibition of cell migration and invasion, sub-G1 cell cycle disruption, apoptosis induction and Raf signalling pathway.
    Meng Q; Tang B; Qiu B
    J BUON; 2019; 24(5):2136-2140. PubMed ID: 31786886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-κB signaling pathway.
    Lu S; Liao QS; Tang L
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7633-7639. PubMed ID: 30536304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
    Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of miR-143 on the apoptosis of osteosarcoma cells.
    Liu H; Wang H; Liu H; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14241-6. PubMed ID: 26823739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells.
    Zuckerman LM; Frames WL; Elsissy JG; Shields TG; de Necochea-Campion R; Mirshahidi HR; Williams NL; Mirshahidi S
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2681-2690. PubMed ID: 30964195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
    Yin Z; Ding H; He E; Chen J; Li M
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27704627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of miR-181b, CYLD, CBX-7, BCL2, and p53 in osteosarcoma patients and correlation with clinicopathological factors.
    Fazli J; Fattah K; Moliani A; Valizadeh A; Bazavar M
    Chem Biol Drug Des; 2023 Jan; 101(1):2-8. PubMed ID: 36098711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-221 Promotes Cell Proliferation and Inhibits Apoptosis in Osteosarcoma Cells by Directly Targeting FBXW11 and Regulating Wnt Signaling.
    Zhang Q; Yin X; Zhang Y
    Arch Med Res; 2021 Feb; 52(2):191-199. PubMed ID: 33131925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.
    Lee DH; Thoennissen NH; Goff C; Iwanski GB; Forscher C; Doan NB; Said JW; Koeffler HP
    Cancer Lett; 2011 Jul; 306(2):161-170. PubMed ID: 21440986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.